Delivery Order SPE2DB20D9103-SPE2DB25FE7E6
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,166.24 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. The award, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a delivery order under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with DLA valued at approximately $500 million through November 2026. The delivery order carries no set-aside designation,...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, valued at $4,166.24, was awarded on June 2, 2025, with an ultimate completion date of June 24, 2025. The contract utilizes no set-aside designation and represents a single delivery order under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems, with an ultimate completion date of October 7, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order represents a single transaction under the company's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,249.24 to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems on September 23, 2025. This firm fixed-price delivery order, with an ultimate completion date of October 15, 2025, represents a single delivery against DMS Pharmaceutical Group's larger indefinite delivery contract with the DLA. The award carries no set-aside designation, allowing the woman-owned small business based in Park Ridge, Illinois to compete directly...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,645.39 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the provision of Mirena 52 mg systems. The contract, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, operates under a firm fixed-price structure with no set-aside designation applied. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,623.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, issued on June 6, 2025, with an ultimate completion date of June 30, 2025, represents a continuation of DMS Pharmaceutical Group's established relationship with DLA as a critical supplier within the federal pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. This contract, issued on July 14, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform this delivery order at its Park Ridge...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The delivery order, valued at $10,415.40 with a firm fixed-price structure, was issued on September 23, 2025, with an ultimate completion date of October 15, 2025. This award carries no set-aside designation and represents a single delivery order under DMS...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,562.31 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA. The awardee, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,415.40 to DMS Pharmaceutical Group Inc. on July 28, 2025, for the supply of Mirena 52 mg systems. The award, which carries an ultimate completion date of August 18, 2025, utilizes a firm fixed-price contract type with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Illinois facility. The...
- SPE2DB20D9103Indefinite Delivery Contract
- SPE2DB20D9103-SPE2DB25FE7E6Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,166.24 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. The award, issued on August 27, 2025, with an ultimate completion date of September 18, 2025, represents a direct purchase under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA. This delivery order carries no set-aside designation, allowing the woman-owned small business to compete on a level playing field within the federal pharmaceutical procurement market. DMS Pharmaceutical Group Inc., a Park Ridge, Illinois-based pharmaceutical wholesaler, serves as a critical supplier within the federal pharmaceutical supply chain through its comprehensive IDC with the DLA valued at $499,999,999 and valid through November 2026. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. The Mirena delivery order exemplifies the company's role in supplying specialized pharmaceutical products, including contraceptive and hormonal devices, to support military health operations. As a woman-owned small business registered in SAM.gov since 2001, DMS Pharmaceutical Group has established a robust portfolio of federal contract awards demonstrating consistent capability in meeting the DLA's pharmaceutical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 8/27/25 |